These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 36507738)

  • 21. Pharmacokinetics and subjective effects of a novel oral LSD formulation in healthy subjects.
    Holze F; Duthaler U; Vizeli P; Müller F; Borgwardt S; Liechti ME
    Br J Clin Pharmacol; 2019 Jul; 85(7):1474-1483. PubMed ID: 30883864
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Population Pharmacokinetic/Pharmacodynamic Modeling of Glenzocimab (ACT017) a Glycoprotein VI Inhibitor of Collagen-Induced Platelet Aggregation.
    Renaud L; Lebozec K; Voors-Pette C; Dogterom P; Billiald P; Jandrot Perrus M; Pletan Y; Machacek M
    J Clin Pharmacol; 2020 Sep; 60(9):1198-1208. PubMed ID: 32500636
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety, tolerability, pharmacokinetics, and pharmacodynamics of fimasartan following single and repeated oral administration in the fasted and fed states in healthy subjects.
    Chi YH; Lee H; Paik SH; Lee JH; Yoo BW; Kim JH; Tan HK; Kim SL
    Am J Cardiovasc Drugs; 2011 Oct; 11(5):335-46. PubMed ID: 21910510
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetic and pharmacodynamic characteristics of aranidipine sustained-release, enteric-coated tablets in healthy Chinese men: a phase I, randomized, open-label, single- and multiple-dose study.
    Jiang J; Tian L; Huang Y; Li Y; Xu L
    Clin Ther; 2008 Jul; 30(7):1290-9. PubMed ID: 18691988
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Single-dose Pharmacokinetics and Pharmacodynamics of Canagliflozin, a Selective Inhibitor of Sodium Glucose Cotransporter 2, in Healthy Indian Participants.
    Devineni D; Polidori D; Curtin C; Stieltjes H; Tian H; Wajs E
    Clin Ther; 2016 Jan; 38(1):89-98.e1. PubMed ID: 26687552
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics of duloxetine hydrochloride enteric-coated tablets in healthy Chinese volunteers: a randomized, open-label, single- and multiple-dose study.
    Zhao RK; Cheng G; Tang J; Song J; Peng WX
    Clin Ther; 2009 May; 31(5):1022-36. PubMed ID: 19539103
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Determination of psilocin and 4-hydroxyindole-3-acetic acid in plasma by HPLC-ECD and pharmacokinetic profiles of oral and intravenous psilocybin in man.
    Hasler F; Bourquin D; Brenneisen R; Bär T; Vollenweider FX
    Pharm Acta Helv; 1997 Jun; 72(3):175-84. PubMed ID: 9204776
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Flashback phenomena after administration of LSD and psilocybin in controlled studies with healthy participants.
    Müller F; Kraus E; Holze F; Becker A; Ley L; Schmid Y; Vizeli P; Liechti ME; Borgwardt S
    Psychopharmacology (Berl); 2022 Jun; 239(6):1933-1943. PubMed ID: 35076721
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Single- and multiple-dose tolerability, safety, pharmacokinetics, and pharmacodynamics of the dual endothelin receptor antagonist aprocitentan in healthy adult and elderly subjects.
    Sidharta PN; Melchior M; Kankam MK; Dingemanse J
    Drug Des Devel Ther; 2019; 13():949-964. PubMed ID: 30962677
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development and validation of an LC-MS/MS method for the bioanalysis of psilocybin's main metabolites, psilocin and 4-hydroxyindole-3-acetic acid, in human plasma.
    Kolaczynska KE; Liechti ME; Duthaler U
    J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Feb; 1164():122486. PubMed ID: 33485158
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Deciphering psilocybin: Cytotoxicity, anti-inflammatory effects, and mechanistic insights.
    Laabi S; LeMmon C; Vogel C; Chacon M; Jimenez VM
    Int Immunopharmacol; 2024 Mar; 130():111753. PubMed ID: 38401463
    [TBL] [Abstract][Full Text] [Related]  

  • 32. First-in-Human Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of an Oral Formulation of DS-1040, an Inhibitor of the Activated Form of Thrombin-Activatable Fibrinolysis Inhibitor, in Healthy Subjects.
    Zhou J; Limsakun T; Yin O; Warren V; Zamora C; Atiee G; Kochan J; Pav J; Kobayashi F; Vashi V; Dishy V
    J Clin Pharmacol; 2019 Dec; 59(12):1669-1677. PubMed ID: 31243790
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serotonin 5-HT
    Erkizia-Santamaría I; Alles-Pascual R; Horrillo I; Meana JJ; Ortega JE
    Biomed Pharmacother; 2022 Oct; 154():113612. PubMed ID: 36049313
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Linagliptin, a dipeptidyl peptidase-4 inhibitor in development for the treatment of type 2 diabetes mellitus: a Phase I, randomized, double-blind, placebo-controlled trial of single and multiple escalating doses in healthy adult male Japanese subjects.
    Sarashina A; Sesoko S; Nakashima M; Hayashi N; Taniguchi A; Horie Y; Graefe-Mody EU; Woerle HJ; Dugi KA
    Clin Ther; 2010 Jun; 32(6):1188-204. PubMed ID: 20637971
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metabolism of psilocybin and psilocin: clinical and forensic toxicological relevance.
    Dinis-Oliveira RJ
    Drug Metab Rev; 2017 Feb; 49(1):84-91. PubMed ID: 28074670
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Application of PK/PD modeling and simulation to dosing regimen optimization of high-dose human regular U-500 insulin.
    de la Peña A; Ma X; Reddy S; Ovalle F; Bergenstal RM; Jackson JA
    J Diabetes Sci Technol; 2014 Jul; 8(4):821-9. PubMed ID: 24876428
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetic and pharmacodynamic assessments of the dipeptidyl peptidase-4 inhibitor PHX1149: double-blind, placebo-controlled, single- and multiple-dose studies in healthy subjects.
    O'Farrell AM; van Vliet A; Abou Farha K; Cherrington JM; Campbell DA; Li X; Hanway D; Li J; Guler HP
    Clin Ther; 2007 Aug; 29(8):1692-705. PubMed ID: 17919550
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Psilocybin modulation of time-varying functional connectivity is associated with plasma psilocin and subjective effects.
    Olsen AS; Lykkebo-Valløe A; Ozenne B; Madsen MK; Stenbæk DS; Armand S; Mørup M; Ganz M; Knudsen GM; Fisher PM
    Neuroimage; 2022 Dec; 264():119716. PubMed ID: 36341951
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics and concentration-effect analysis of intravenous RGD891, a platelet GPIIb/IIIa antagonist, using mixed-effects modeling (NONMEM).
    Zannikos PN; Rohatagi S; Jensen BK; DePhillips SL; Rhodes GR
    J Clin Pharmacol; 2000 Oct; 40(10):1129-40. PubMed ID: 11028252
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics and Tolerability of Rufinamide Following Single and Multiple Oral Doses and Effect of Food on Pharmacokinetics in Healthy Chinese Subjects.
    Xu M; Ni Y; Zhou Y; He X; Li H; Chen H; Li W
    Eur J Drug Metab Pharmacokinet; 2016 Oct; 41(5):541-8. PubMed ID: 26294172
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.